A detailed history of Foresight Group LTD Liability Partnership transactions in Astrazeneca PLC stock. As of the latest transaction made, Foresight Group LTD Liability Partnership holds 217,824 shares of AZN stock, worth $15.3 Million. This represents 3.92% of its overall portfolio holdings.

Number of Shares
217,824
Holding current value
$15.3 Million
% of portfolio
3.92%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$65.37 - $77.96 $14.2 Million - $17 Million
217,824 New
217,824 $24.5 Billion

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $218B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Foresight Group LTD Liability Partnership Portfolio

Follow Foresight Group LTD Liability Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresight Group LTD Liability Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Foresight Group LTD Liability Partnership with notifications on news.